Harvester Eliminates Multiple Pipetting

Biochemists, pharmacologists, and cell biologists frequently need to perform assays requiring the detection and quantitation of radioisotopes during such procedures as receptor binding assays, antigen detecting, metabolic/enzymatic as- says, and protein or antibody labeling. These assays invariably demand the analysis of a large number of samples, necessitating multiple pipetting. Consequently, such assays are prone to pipetting errors. Cambridge Technology Inc., based in Watertown, Mass., now

Written byV Richard Sheridan
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Biochemists, pharmacologists, and cell biologists frequently need to perform assays requiring the detection and quantitation of radioisotopes during such procedures as receptor binding assays, antigen detecting, metabolic/enzymatic as- says, and protein or antibody labeling. These assays invariably demand the analysis of a large number of samples, necessitating multiple pipetting. Consequently, such assays are prone to pipetting errors. Cambridge Technology Inc., based in Watertown, Mass., now markets the Model 2000 PHI) Sample Harvester, designed to obviate the need for repetitive pipetting and reducing greatly the time required to perform such assays. The Model 2000 harvests 24 samples at a time onto 25mm diameter collection sites and will insert the samples into 12- x 75-mm test tubes, gamma tubes, minivials, or standard 20-mi scintillation vials. Trays are also available for depositing samples directly into Hewlett-Packard or Beckman 12 liquid scintillation vial cassettes; the basic system, priced at $4,800, includes a choice of ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies